BSE filing, NSE: UCOBANK. Summary written from the filing by ALFA Finder's alert engine.
UCO Bank: key numbers
- Share price
- ₹22.07
- Market cap
- ₹27,675 Cr
- Revenue (annual)
- ₹26,281 Cr
- Net profit (annual)
- ₹2,768 Cr
- P/E (TTM)
- 9.3×Sector 19.7×
- Promoter holding
- 90.95%+0.00% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UCO Bank
All →UCO Bank Management Change
UCO Bank's Central Government nominated Shri Mohamed Ashraf J S as a director, replacing Shri Hari Har Mishra, effective 23 October 2026. The filing gives the appointment details and confirms no SEBI debarment.
UCO Bank Results Update
UCO Bank reported Q2 FY27 net profit of Rs.786 Crore, up 26.77% Y-o-Y. Total business grew 18.81% Y-o-Y to Rs.6,37,280 Crore with NPA at 1.96%.
UCO Bank Investor Presentation: Key Takeaways
UCO Bank reported strong Q2 FY27 performance with Net Profit rising 26.77% YoY to ₹786 Cr. Focus remains on RAM segment growth and improving asset quality with NNPA at 0.18%.
- Call
- Guides 14% growth
UCO Bank Q2 FY27 Results: Net Profit ₹785.6 Cr, Up 26.8% YoY
UCO Bank reported revenue from operations of ₹7,286 Cr (+11.5% YoY) and net profit of ₹785.6 Cr (+26.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹785.6 Cr · +26.8% YoY
UCO Bank Credit Rating
UCO Bank received a credit rating reaffirmation of 'AA/Stable' from India Ratings & Research Pvt Ltd for its long-term instruments aggregating to Rs. 1,500 Crore.
- Value
- ₹1,500 Cr
UCO Bank Other Announcement
UCO Bank filed its half-yearly ISIN specification statement for listed debt securities per SEBI Master Circular Chapter VIII. No new transaction or event is reported.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.